BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it has scheduled a meeting for the investment community on Tuesday, October 30 in New York City. The meeting will review the status of the company’s research and development programs, and coincide with the release of its financial results for the third quarter ending September 30, 2007.
